Monisha Sharma MSPH, PhD

Acting Assistant Professor, Global Health, University of Washington

Dr. Monisha Sharma, MSPH, PhD, is an Acting Assistant Professor in the Department of Global Health. She received her Masters in Infectious Disease Epidemiology from Johns Hopkins University and her PhD in Epidemiology from the University of Washington. Her research interests include mathematical modeling and cost-effectiveness analyses of HIV testing and linkage to care interventions in sub-Saharan Africa. She is the Principal Investigator of a K01 award to design an intervention into increase men’s uptake of HIV self-testing and clinic linkage in Uganda. During her joint postdoctoral fellowship with UW and the Harvard School of Public Health, she worked to develop a mathematical model of HIV/HPV co-infection to project the cost-effectiveness of cervical cancer prevention strategies in South Africa. She is currently working on a scale up project of Assisted Partner Notification services in Kenya and collaborates with the Institute for Disease Modeling to project the impact of scaling up point-of-care viral load monitoring for patients on ART in sub-Saharan Africa.

Publications

  1. Chen, AW, Wong, ES, Winer, RL, Sharma, M, Gray, KE. Effects of School-Entry Vaccination Mandates on Adolescent Human Papillomavirus Vaccination Uptake: United States, 2008-2023. Am J Public Health. 2026; :e1-e4. doi: 10.2105/AJPH.2026.308635. PubMed PMID:42623580 .
  2. Abu-Alya, A, Gallagher, A, Xiong, W, Baird-Daniel, E, Carlson, S, Fong, C et al.. Associations and Predictive Value of Neuroimaging Characteristics for Extubation Failure in Moderate to Severe Traumatic Brain Injury: An Exploratory Analysis. Neurocrit Care. 2026; :. doi: 10.1007/s12028-026-02615-y. PubMed PMID:42581192 .
  3. Malhotra, A, Patel, N, Kaftan, D, Chen, Y, Arrouzet, C, Saravis, A et al.. Cost-effectiveness of providing pre-exposure and post-exposure prophylaxis for the prevention of HIV via online pharmacies in western Kenya: a modelling study. Lancet Glob Health. 2027; :103977. doi: 10.1016/j.langlo.2026.103977. PubMed PMID:42567175 .
  4. Hathaway, CL, Tran, J, van Schalkwyk, C, Kuhn, L, Rao, DW, Barnabas, RV et al.. Health economic impact and cost threshold for switching from bivalent to nonavalent HPV vaccination for preadolescent girls in KwaZulu Natal, South Africa: A mathematical modeling analysis accounting for the HIV epidemic. J Acquir Immune Defic Syndr. 2026; :. doi: 10.1097/QAI.0000000000003936. PubMed PMID:42480997 .
  5. Ortblad, KF, Meisner, A, Omollo, V, Kareithi, T, Roche, SD, Ong'wen, P et al.. Effectiveness of pharmacy-based HIV pre- and post-exposure prophylaxis delivery: a cluster-randomized trial in Kenya. medRxiv. 2026; :. doi: 10.64898/2026.06.26.26356703. PubMed PMID:42428077 PubMed Central PMC13345420.
Search PubMed